Literature DB >> 24037729

Cortical excitability differences in hand muscles follow a split-hand pattern in healthy controls.

Parvathi Menon1, Matthew C Kiernan, Steve Vucic.   

Abstract

INTRODUCTION: Differences in cortical and axonal excitability may underlie preferential atrophy of abductor pollicis brevis (APB) and first dorsal interosseous (FDI) in amyotrophic lateral sclerosis, termed the split-hand. Consequently, this study aimed to determine whether differences in excitability follow a split-hand pattern across the intrinsic hand muscles.
METHODS: Excitability studies were undertaken using threshold tracking techniques in 26 healthy controls with responses recorded over APB, FDI, and abductor digiti minimi.
RESULTS: Short interval intracortical inhibition was significantly greater from the APB and FDI. In addition, motor evoked potential amplitude was greater, while cortical silent period was longer from APB and FDI. At a peripheral level, the strength-duration time constant was greater when recorded over APB.
CONCLUSIONS: This study establishes that differences in cortical excitability follow the split-hand pattern in healthy controls, a finding potentially explained by evolution of specialized activity of APB/FDI in complex hand tasks. Muscle Nerve 49: 836-844, 2014.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  TMS; axonal excitability; cortical excitability; hypothenar muscles; thenar muscles

Mesh:

Year:  2014        PMID: 24037729     DOI: 10.1002/mus.24072

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis.

Authors:  Neil G Simon; Michael Lee; Jong Seok Bae; Eneida Mioshi; Cindy S-Y Lin; Casey M Pfluger; Robert D Henderson; Steve Vucic; Michael Swash; David Burke; Matthew C Kiernan
Journal:  J Neurol       Date:  2015-04-07       Impact factor: 4.849

Review 2.  Pathophysiological and diagnostic implications of cortical dysfunction in ALS.

Authors:  Nimeshan Geevasinga; Parvathi Menon; P Hande Özdinler; Matthew C Kiernan; Steve Vucic
Journal:  Nat Rev Neurol       Date:  2016-09-23       Impact factor: 42.937

3.  Age-related changes in motor cortical representation and interhemispheric interactions: a transcranial magnetic stimulation study.

Authors:  Elisabetta Coppi; Elise Houdayer; Raffaella Chieffo; Francesca Spagnolo; Alberto Inuggi; Laura Straffi; Giancarlo Comi; Letizia Leocani
Journal:  Front Aging Neurosci       Date:  2014-08-11       Impact factor: 5.750

4.  Differences in Dysfunction of Thenar and Hypothenar Motoneurons in Amyotrophic Lateral Sclerosis.

Authors:  Jia Fang; Liying Cui; Mingsheng Liu; Yuzhou Guan; Xiaoguang Li; Dawei Li; Bo Cui; Dongchao Shen; Qingyun Ding
Journal:  Front Hum Neurosci       Date:  2016-03-07       Impact factor: 3.169

5.  Regional motor cortex dysfunction in amyotrophic lateral sclerosis.

Authors:  Parvathi Menon; Con Yiannikas; Matthew C Kiernan; Steve Vucic
Journal:  Ann Clin Transl Neurol       Date:  2019-06-28       Impact factor: 4.511

Review 6.  The Dying Forward Hypothesis of ALS: Tracing Its History.

Authors:  Andrew Eisen
Journal:  Brain Sci       Date:  2021-02-27

Review 7.  The strength of corticomotoneuronal drive underlies ALS split phenotypes and reflects early upper motor neuron dysfunction.

Authors:  Andrew Eisen; Peter Bede
Journal:  Brain Behav       Date:  2021-10-28       Impact factor: 2.708

8.  The reliability of repeated TMS measures in older adults and in patients with subacute and chronic stroke.

Authors:  Heidi M Schambra; R Todd Ogden; Isis E Martínez-Hernández; Xuejing Lin; Y Brenda Chang; Asif Rahman; Dylan J Edwards; John W Krakauer
Journal:  Front Cell Neurosci       Date:  2015-09-01       Impact factor: 5.505

9.  Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis.

Authors:  Parvathi Menon; Matthew C Kiernan; Steve Vucic
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

10.  Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant).

Authors:  Steve Vucic; Julie Ryder; Linda Mekhael; Henderson Rd; Susan Mathers; Merilee Needham; Schultz Dw; Kiernan Mc
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.